There is hope for us

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

tada

Rank: President [?]

Points: 7750 [?]

Votes: 40 Score: 3.4 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

There is hope for us

posted on Jan 08, 2018 05:10PM

This morning at the JP Morgan conference Celgene announced that they were buying Impact Biomedicines(private) for as much as $7 billion. This is a CVR type deal where Impact would get $1.1 billion up front, $1.4 billion of milestone payments and up to a maximum of $4.5 billion of sales milestones. This deal was done for a cast off cancer drug from Sanofi, fedratinib.

Yes these deals can happen long before phase III trials are complete.

dyodd

tada

8 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply